Cytori Cell Research Institute (TSE:3750) EBIT per Share : 円-93.34 (TTM As of Dec. 2023)

View and export this data going back to 2004. Start your Free Trial

What is Cytori Cell Research Institute EBIT per Share?

Cytori Cell Research Institute's EBIT per Share for the three months ended in Dec. 2023 was 円-8.30. Its EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2023 was 円-93.34.

During the past 3 years, the average EBIT per Share Growth Rate was -66.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for Cytori Cell Research Institute's EBIT per Share or its related term are showing as below:

TSE:3750' s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -66.6 Med: 4.8 Max: 38.6
Current: -66.6

During the past 13 years, the highest 3-Year average EBIT per Share Growth Rate of Cytori Cell Research Institute was 38.60% per year. The lowest was -66.60% per year. And the median was 4.80% per year.

TSE:3750's 3-Year EBIT Growth Rate is ranked worse than
93.18% of 1305 companies
in the Biotechnology industry
Industry Median: 3.4 vs TSE:3750: -66.60

Cytori Cell Research Institute's EBIT for the three months ended in Dec. 2023 was 円-74 Mil.

Cytori Cell Research Institute EBIT per Share Historical Data

The historical data trend for Cytori Cell Research Institute's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cytori Cell Research Institute EBIT per Share Chart

Cytori Cell Research Institute Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

EBIT per Share

Get a 7-Day Free Trial

94.03

56.14

-69.61

3.16

-116.12

Cytori Cell Research Institute Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
EBIT per Share	Get a 7-Day Free Trial															-15.48	-46.96	-14.24	-23.84	-8.30

Cytori Cell Research Institute EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

Cytori Cell Research Institute's EBIT per Share for the fiscal year that ended in Mar. 2023 is calculated as

	EBIT per Share		(A: Mar. 2023 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	-1036.835	/	8.929
=	-116.12

Cytori Cell Research Institute's EBIT per Share for the quarter that ended in Dec. 2023 is calculated as

	EBIT per Share		(Q: Dec. 2023 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	-74.111	/	8.928
=	-8.30

EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was 円-93.34

Cytori Cell Research Institute (TSE:3750) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.

Cytori Cell Research Institute EBIT per Share Related Terms

Thank you for viewing the detailed overview of Cytori Cell Research Institute's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Cytori Cell Research Institute (TSE:3750) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cytori Cell Research Institute Inc (TSE:3750) » Definitions » EBIT per Share

Comparable Companies

Traded in Other Exchanges

N/A

Address

1-1-1 Otemachi, Otemachi Park Building, Chiyoda-ku, Tokyo, JPN, 100-0004

Website

https://www.cytori.co.jp

Cytori Cell Research Institute Inc developing a new clinical approach to cell therapy to provide better medical care to patients by providing medical care that responds to unmet medical needs based on innovative regenerative medicine. Its product pipeline includes Habeo; ECCO-50 and others.

Cytori Cell Research Institute (TSE:3750) Headlines

No Headlines